| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 1275-1282, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
D Goldman, Y Cho, M Zhao, A Casadevall and SC Lee
Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Rats, like humans, have extremely effective immune mechanisms for controlling pulmonary Cryptococcus neoformans infection. The mechanism(s) responsible for efficient immunity in rat experimental infection is unknown. Recently, induction of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) have been implicated as an important microbicidal mechanism by which activated macrophages effect cytotoxicity against microbes. In this report, we investigated the expression of iNOS in rat pulmonary cryptococcosis. Localization and regulation of NO production was studied by immunohistochemistry for iNOS in conjunction with immunohistochemistry for cell markers, cytokines, and cryptococcal capsular polysaccharide. iNOS immunoreactivity was detected in macrophages, neutrophils, vascular endothelium, and respiratory epithelium. Double-immunolabeling studies revealed that the most prominent iNOS immunoreactivity was localized to epithelioid macrophages (CD11b/c+) within granulomas; CD4+ and CD8+ T cells were numerous around granulomas but did not express iNOS. iNOS immunoreactivity was detected in a selective population of epithelioid macrophages within some granulomas but not others. iNOS- granulomas were identical to iNOS+ granulomas with respect to morphology and immunohistochemical profiles. Macrophage iNOS immunoreactivity was detected 1 week after infection in one out of four rats and was strongly expressed in all rats at 2 weeks (in up to 50 percent of the granulomas) but declined considerably by 25 days. iNOS expression coincided with granuloma formation and preceded a decrease in lung fungal burden, suggesting an anticryptococcal role for NO. By double labeling, cytokines that have been shown to promote (interferon-gamma, granulocyte/macrophage colony-stimulating factor) and inhibit (transforming growth factor-beta) macrophage iNOS expression were detected around iNOS+ granuloma. iNOS immunoreactivity was expressed in selected neutrophils (1 and 2 weeks) and endothelial cells (1 and 2 weeks and 25 days) in the inflamed lung. Airway iNOS immunoreactivity was limited to the luminal border of rare bronchiolar epithelial cells. iNOS immunoreactivity was not detected in uninfected rats. The present study provides the first evidence for association of iNOS expression with protective cellular responses to cryptococcal infection in vivo.
This article has been cited by other articles:
 |
|
 |
|
  U. Muller, W. Stenzel, G. Kohler, C. Werner, T. Polte, G. Hansen, N. Schutze, R. K. Straubinger, M. Blessing, A. N. J. McKenzie, et al. IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans J. Immunol., October 15, 2007; 179(8): 5367 - 5377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mylonakis, R. Moreno, J. B. El Khoury, A. Idnurm, J. Heitman, S. B. Calderwood, F. M. Ausubel, and A. Diener Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis Infect. Immun., July 1, 2005; 73(7): 3842 - 3850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Monari, E. Pericolini, G. Bistoni, A. Casadevall, T. R. Kozel, and A. Vecchiarelli Cryptococcus neoformans Capsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages J. Immunol., March 15, 2005; 174(6): 3461 - 3468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. He, A. Casadevall, S. C. Lee, and D. L. Goldman Phagocytic Activity and Monocyte Chemotactic Protein Expression by Pulmonary Macrophages in Persistent Pulmonary Cryptococcosis Infect. Immun., February 1, 2003; 71(2): 930 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. Suschek, E. Bonmann, A. Kapsokefalou, K. Hemmrich, H. Kleinert, U. Forstermann, K.-D. Kroncke, C. Mahotka, and V. Kolb-Bachofen Revisiting an Old Antimicrobial Drug: Amphotericin B Induces Interleukin-1-Converting Enzyme as the Main Factor for Inducible Nitric-Oxide Synthase Expression in Activated Endothelia Mol. Pharmacol., October 1, 2002; 62(4): 936 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-S. Choi, P. R. Rai, H. W. Chu, C. Cool, and E. D. Chan Analysis of Nitric Oxide Synthase and Nitrotyrosine Expression in Human Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 178 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rivera, J. Mukherjee, L. M. Weiss, and A. Casadevall Antibody Efficacy in Murine Pulmonary Cryptococcus neoformans Infection: A Role for Nitric Oxide J. Immunol., April 1, 2002; 168(7): 3419 - 3427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Goldman, S. C. Lee, A. J. Mednick, L. Montella, and A. Casadevall Persistent Cryptococcus neoformans Pulmonary Infection in the Rat Is Associated with Intracellular Parasitism, Decreased Inducible Nitric Oxide Synthase Expression, and Altered Antibody Responsiveness to Cryptococcal Polysaccharide Infect. Immun., February 1, 2000; 68(2): 832 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Facchetti, W. Vermi, S. Fiorentini, M. Chilosi, A. Caruso, M. Duse, L. D. Notarangelo, and R. Badolato Expression of Inducible Nitric Oxide Synthase in Human Granulomas and Histiocytic Reactions Am. J. Pathol., January 1, 1999; 154(1): 145 - 152. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
